Continued Efficacy and Safety of Apomorphine in Patients With Late-Stage Parkinsons Disease

This study has been completed.
Sponsor:
Information provided by:
Mylan Bertek Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00200525
First received: September 13, 2005
Last updated: December 15, 2005
Last verified: September 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: June 2002
  Estimated Primary Completion Date: No date given